/Companies

Sixfold Bioscience

YC W18

London, GB · Founded 2018 · 27 employees · 8 known investors

Find your way into Sixfold Bioscience

Sign up to see every warm intro you have to Sixfold Bioscience

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sixfold Bioscience team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.

Founders & leadership· Y Combinator alumni (W18)

Sixfold Bioscience was founded in 2018 by George Foot and Anna Perdrix Rosell.

GFGeorge Foot
George FootFounder/co-CEO
APAnna Perdrix Rosell
Anna Perdrix RosellCo-FounderFounder of Sixfold Bioscience, an RNA delivery technology company for biotech. Perdrix Rosell has background training in oncology and plant science.
TF
Tina FlatauNamed on SEC filing
ZB
Zuzanna Brzosko

Investors · 8

Also in the syndicate · 1

Lombard Street Ventures

Funding

SEC filings, press & company announcements

$12.8M disclosed across 2 rounds · 2021

▶$2.3MraisedAug 2021 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tina FlatauDirector, Promoter
  • Anna Perdrix RosellExecutive Officer, Director, Promoter
  • George William FootExecutive Officer, Director, Promoter
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

Sixfold AiSixfold provides an AI-powered underwriting platform for insurance carriers, MGAs, and reinsurers to automate and accelerate the underwriting process. The platform processes submissions across multiple business lines and continents, enabling underwriters to focus on complex decisions while AI handles routine work.
NanograbNanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.
Salesforce VenturesSalesforce Ventures is a venture capital firm that invests in enterprise software companies globally, focusing on generative AI, data infrastructure, security, vertical and horizontal applications, and emerging areas like energy and space.
Rejuvenation Technologies Inc.Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
Nuntius TherapeuticsNuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.
Avro Life ScienceAvro Life Sciences develops platform technology for novel drug delivery through passive transdermal administration. The company operates in the biotech sector, focusing on dermatological and systemic therapeutics.

Companies working in the same space as Sixfold Bioscience.

Legal entities · 1

corporate structure
Sixfold Bioscience Inc.

In the news

Frequently asked questions

What does Sixfold Bioscience do?
Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
Who founded Sixfold Bioscience?
Sixfold Bioscience was founded by George Foot, Anna Perdrix Rosell in 2018.
Who are Sixfold Bioscience's investors?
Sixfold Bioscience's investors include Jude Gomila, Pi Campus, Y Combinator, Cantos Ventures, Fundamental Ventures, Lombardstreet Ventures, The Venture Collective.
How much funding has Sixfold Bioscience raised?
Sixfold Bioscience has disclosed $12.8M raised across 2 rounds.
Where is Sixfold Bioscience headquartered?
Sixfold Bioscience is headquartered in London, GB.